Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States.

Choong CK, Belger M, Koch AE, Meyers KJ, Marconi VC, Abedtash H, Faries D, Krishnan V

Open source

DOI
10.1007/s12325-022-02267-2
Published
2022 Oct
Container
Advances in therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12325-022-02267-2,
  title = {Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States.},
  author = {Choong CK and Belger M and Koch AE and Meyers KJ and Marconi VC and Abedtash H and Faries D and Krishnan V},
  year = {2022},
  journal = {Advances in therapy},
  doi = {10.1007/s12325-022-02267-2},
  url = {https://doi.org/10.1007/s12325-022-02267-2}
}

RIS

TY  - JOUR
TI  - Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States.
AU  - Choong CK
AU  - Belger M
AU  - Koch AE
AU  - Meyers KJ
AU  - Marconi VC
AU  - Abedtash H
AU  - Faries D
AU  - Krishnan V
PY  - 2022
JO  - Advances in therapy
DO  - 10.1007/s12325-022-02267-2
UR  - https://doi.org/10.1007/s12325-022-02267-2
ER  - 

APA

CK, C., M, B., AE, K., KJ, M., VC, M., H, A., D, F., & V, K. (2022). Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States.. Advances in therapy. https://doi.org/10.1007/s12325-022-02267-2

Source records